Research Challenges 30-Year-Old Standard of Care for Lupus Patients
SUNY Downstate Health Sciences UniversityA promising new treatment for lupus challenges the way physicians currently treat patients suffering with lupus kidney disease. A study shows promising results of the use of mycophenolate mofetil (MMF), an immunosuppressive drug used primarily to combat organ rejection in transplant patients.